Bone mineral density (BMD) in male patients with Parkinson's disease

International Journal of Neuroscience

Volumn 122, Issue 9, 2012, Pages 523-527

  Daniel, Sara K ^a   Lansang, M Cecilia ^b   Okun, Michael S ^c  

^a University of Florida   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

bone; neurodegenerative; prevention

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FALLING; FEMUR NECK; FRAGILITY FRACTURE; HEALTH PROMOTION; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; OUTPATIENT DEPARTMENT; PARKINSON DISEASE; PREVALENCE; SCREENING; SPINE; UNIFIED PARKINSON DISEASE RATING SCALE;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84864925792     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.685530     Document Type: Article

References (30)

1. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with Parkinsonism and anti-Parkinson drugs. Calcif Tissue Int. 2007;81:153-61. (Pubitemid 47373359)
2. Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: Frequency, impact and identifying factors. J Neurol. 2005;252:1310-15. (Pubitemid 41699019)
3. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273-78. (Pubitemid 27495628)
4. National Osteoporosis Foundation website. [cited 2010 May 26]. Available from: www.nof.org.
5. Gullberg B, Johnell O, Kanis JA.World-wide projections for hip fracture. Osteoporos Int. 1997;7:407-13. (Pubitemid 27443065)
6. Jiang HX, Majumdar SR, Dick DA, Moreau M, Raso J, Otto DD, Johnston DW. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res. 2005;20:494-500. (Pubitemid 40297910)
7. Ebeling PR. Clinical practice: Osteoporosis in men. N Engl J Med. 2008;358(14):1474-82.
8. Looker AC, Melton LJ, Harris TB, Borrud LG, Shepard JA. Prevalence and trends in lower femur bone density among older US adults: NHANES 2005-2006 compared With NHANES III. J Bone Min Res. 2010;25(1):64-71.
9. Invernizzi M, Carda S, Viscontini GS, Cisari C. Osteoporosis in Parkinson's disease. Parkinsonim Relat Disord. 2009;15(5):339-46.
10. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol. 2000;247(Suppl. 2):II3-10.
11. Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, LangstonWJ, Di MonteDA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D Jr, Price DL. The etiopathogenesis of Parkinson disease and suggestions for future research Part I. J Neuropathol Exp Neurol. 2007;66(4):251-7. (Pubitemid 46559017)
12. Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Kim HK, Ryu JS, Kim GS, Lee MC, Chung SJ, Koh JM. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease. Calcif Tissue Int. 2010;86(2):132-41.
13. Gnädinger M, Mellinghoff HU, Kaelin-Lang A. Parkinson's disease and the bones. Swiss Med Wkly. 2011;141:w13154.
14. Braak H, Del Tredici K, Rüb U, De Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24(2):197-211. (Pubitemid 36007810)
15. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. 1994.
16. Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380-90.
17. U.S. Department of Health and Human Services. Bone health and osteoporosis: A report of the surgeon general. U.S. Department of Health and Human Services, Office of the Surgeon General; 2004.
18. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001-5. (Pubitemid 23191067)
19. Wehren LE, Hawkes WG, Orwig DL, Hebel JR, Zimmerman SI, Magaziner J. Gender differences in mortality after hip fracture: The role of infection. J BoneMiner Res. 2003;18:2231-37. (Pubitemid 37463317)
20. Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D. Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int. 2001;69:218-21. (Pubitemid 33035391)
21. Center for Disease Control and Prevention (CDC); National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. U.S. Department of Health and Human Services, CDC, 2005-2006. [cited 2012 Mar 21]. Available from: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/nhanes0506. htm
22. Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol. 2008;64(5):485-91.
23. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. Bone mineral density in hip-fracture patients with Parkinson's disease: A case-control study. Arch Phys Med Rehabil. 2006;87:1459-62. (Pubitemid 44754852)
24. National Osteoporosis Foundation. What you should know about calcium. [cited 2010 Jul 7]. Available from: http://www.nof.org/prevention/calcium2.htm
25. Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism in older adults with Parkinson's disese. Age Ageing 2009;38(6):675-80.
26. KamideN, Fuluda M, MiuraH. The relationship between bone density and the physical performance of ambulatory patients with Parkinson's disease. J Physiol Anthropol. 2008;27(1):7-10.
27. Bezza A, Ouzzif Z, Naji H, Achemlal L, Mounach A, Nouijai M, Bourazza A, Mossadeq R, El Maghraoui A. Prevalence and risk factors of osteoporosis in patients with Parkinson's disease. Rheumatol Int. 2008;28(12):1205-9.
28. Jones PD, Stone D, Jones S, Lewis B. Parkinson's disease and bone health. Age Aging 2010;39(2):278.
29. EngML, Lyons KE, Pahwa R. Prevalence of bone mineral density screening in Parkinson's disease clinic outpatients. MovDisord. 2006;21(12):2265-6. (Pubitemid 46140459)
30. Fink HA, Kuskowski MA, Orwoll ES, Cauley JA, Ensrud KE; Osteoporotic Fractures in Men (MrOS) Study Group. Association between Parkinson's disease and low bone density and falls in older men: The osteoporotic fractures in men study. J Am Geriatr Soc. 2005;53(9):1559-64. (Pubitemid 41602447)